Full-Time
Regional Vice President – Business Development
Hospice
Posted on 10/6/2025
BrightSpring Health Services
10,001+ employees
Home-based and community health services, pharmacy
No salary listed
Moody, AL, USA
In Person
 Business & Strategy (1) |
|---|
- Bachelor's degree in Marketing, Business Administration or related field
- Ten years experience in hospice and/or home health business development
- 7 years experience leading a team of business development professionals
- Proven success in the development and execution of strategic marketing plans
- Excellent presentation and public speaking and sales skills
- Experience in strategic planning and collaboration with executive, sales, product development and key operational groups
- A deep and broad professional network that aligns to our target client base preferred
- Demonstrated track record in building new book of business, client relationship management, and evidence of closing and growing accounts preferred
- Develops and implements the sales and marketing strategies to grow and expand the Hospicebusiness in the region
- Ensures alignment and implementation of sales strategy through discussions with the arealeadership team
- Monitors and maintains data on market area including competitors and marketing strategies anddevelops a comprehensive marketing plan designed to meet budgetary volume projections
- Manages and directs the Area Operations Leaders in planning in-services, presentations, and inaddressing issues with referral sources
- Initiates and coordinates contract negotiations with agencies, funding sources, facilities, insurancecompanies, and managed care organizations
- Supports and promotes company philosophy to Key Opinion Leaders/C-Suite/Large accounts inconjunction with Ops/Clinical/AVP
- Develops and maintaining comprehensive working knowledge of organization's markets includingbut not limited to key referral sources, competitors, governmental agencies, and major payergroups and applies this knowledge to effective sales planning and positive public relations
- Monitors current industry and marketplace changes and opportunities for competitive advantage
- Participates and contributes to the annual budgeting process for the Hospice Division for therespective area of responsibility
- Holds leaders (business development) and teams accountable for the achievement of monthly,quarterly, and annual budgets and business / clinical quality goals
- Provides leadership, mentoring, coaching and development to direct reports
- Responsible for reporting on plans and achievement of business, admission and clinical / qualitygoals to division leadership
- Responsible for recruiting, interviewing, hiring, and training of direct reports
- Monitors turnover in the area of responsibility and strives to maintain turnover at target levels orbelow Ensures proper hiring, training and development of newly hired staff
- Works closely withsupport departments to achieve budget targets, recruiting and retention metrics, and ongoingtraining and development
- Routine collaboration with payer contracting to negotiate the most advantageous contractspossible
- Monitor metrics proactively to effect change in a positive direction before month end
- Collaborate with business partners and use appropriate resources to accurately forecast monthlyadmissions/growth
- Assigned territory and area of operation can change based on business need
- A deep and broad professional network that aligns to our target client base preferred
- Demonstrated track record in building new book of business, client relationship management, and evidence of closing and growing accounts preferred
BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Simplify's Take
What believers are saying
- Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
- Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
- Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.
What critics are saying
- Money Message ransomware stole 2M records including SSNs in March 2023 breach.
- DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
- Pomerantz investigates securities fraud by BrightSpring officers as of 2026.
What makes BrightSpring Health Services unique
- BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
- PharMerica dispenses 40 million prescriptions annually to 4 million patients.
- Provider services target intellectual disabilities via home-based behavioral health.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.
BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.
BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.
BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.
BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.